NL-OMON35434招募中4 期
Comparison of the everolimus eluting (XIENCE-V*/XIENCE-PRIME* or PROMUS* stent) with the biolimus A9 eluting NOBORI* stent in all-comers: a randomized open label study. - The COMPARE II trial
Overige Ziekenhuizen0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients referred for PCI according to dutch and european guidelines
- •Age between 18-85 years
排除标准
- •1 Expected non-adherence to dual antiplatelet therapy for 1 year (e.g: known allergy to ASA or thienopyridines like clopidogrel)
- •2 Expected major surgery within 30 days (these patients will receive bare metal stents)
- •3 Cardiogenic shock (Kilip class 4)
- •4 Previous PCI procedures with implantation of drug eluting stents within 1 year.
- •5 Expected loss for follow up
- •6 Enrollment in an investigative stent study with different stents
- •7 Inability to implant Nobori or Xience-V / Promus stent(s)
研究者
相似试验
招募中
4 期
Comparison of the everolimus eluting XIENCE-V* stent with the paclitaxel eluting TAXUS* stent in all-comers: a randomized open label study.NL-OMON35195Medisch Centrum Rijnmond-Zuid1,600
Unknown
4 期
COMPARE-II- Vasomotion and Imaging SubstudyCoronary Artery DiseaseNCT01329237University of Freiburg50
尚未招募
不适用
Comparison of everolimus eluing stent and zorarolimus eluting stent in long coronary artery lesioDiseases of the circulatory systemKCT0000208Pusan National University Yangsan Hospital600
已完成
4 期
Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold StentsCoronary Artery DiseaseNCT01711931University of Freiburg240
已完成
4 期
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial InfarctionMyocardial InfarctionNCT01347554Yonsei University461